Zila has selected DentalMed Russian Alliance to be the exclusive distributor of ViziLite Plus with TBlue in Russia and Belarus. ViziLite Plus with TBlue is an FDA-approved medical device for the early detection of oral cancer.
"The marketing of ViziLite Plus in Russia and Belarus represents a solid step in our plan to provide this lifesaving product outside the U.S.," stated David Bethune, chairman and CEO of Zila, in a press release. "DentalMed has ties to the Russian National Institute of Adaptation of Marketing Strategies and has broad experience launching professional dental products in Russia."
.RbyOLNR6ps.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&w=100&auto=format%2Ccompress&q=70)
.hpp4JFpXkV.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=167&w=250&auto=format%2Ccompress&q=70)
